Exodus Point Capital Management, LP Reneo Pharmaceuticals, Inc. Transaction History

Exodus Point Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$5.44 - $8.13 $959,284 - $1.43 Million	-176,339 Reduced 31.75%	378,977 $2.89 Million
Q2 2023 Aug 10, 2023	BUY	$5.44 - $10.5 $1.68 Million - $3.25 Million	309,529 Added 125.93%	555,316 $3.64 Million
Q1 2023 May 11, 2023	BUY	$2.44 - $6.42 $261,409 - $687,806	107,135 Added 77.27%	245,787 $1.47 Million
Q4 2022 Feb 13, 2023	BUY	$1.8 - $3.52 $249,573 - $488,055	138,652 New	138,652 $323,000

31M

50.8K

Ticker RPHM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,479,600
Market Cap $41.1M
Description
Reneo Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, focuses on the development of therapies for patients with rare genetic mitochondrial diseases. It develops REN001, a selective peroxisome proliferator-activated receptor delta agonist, which is in Phase IIb clinical trial in patients with primary mitochondrial myopathies, as w...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.